|
| View:
Latest News | Top Stories |
|
| 1.
|
Medizone International Takes Aim at the Bioterrorism Countermeasures Arena
-
PR Newswire
-
2 hours, 19 minutes ago
Medizone International, Inc. announced today that in tests involving its proprietary AsepticSure technology, it continues to break "6 log" decontamination barriers, this time with two very different spore forming bacteria, Claustridium difficile and Bacillis subtilis.
|
|
| 2.
|
Myriad Pharmaceuticals Initiates Phase 2b Study of MPC-4326 in a Genetically-Identified Responder Population
-
GlobeNewswire
-
2 hours, 54 minutes ago
SALT LAKE CITY -- Myriad Pharmaceuticals Inc. today announced the initiation of a Phase 2b study of MPC-4326, a first-in-class, small molecule inhibitor of HIV-1 maturation.
|
|
| 3.
|
Eleven Rigel Product Candidate Presentations at 2009 ASH Meeting
-
PR Newswire
-
Tue 7:30 am ET
Rigel Pharmaceuticals, Inc. today announced that eleven presentations on preclinical studies of the company's product candidates will be given at the upcoming American Society of Hematology Meeting and Exposition in New Orleans, Louisiana from December 5-8, 2009.
|
|
| 4.
|
Spectrum Pharmaceuticals Announces ZEVALIN® Data Presentations at the 51st Annual Meeting of the American Society of Hematology in New Orleans
-
Business Wire
-
Tue 7:00 am ET
IRVINE, Calif.----Spectrum Pharmaceuticals, Inc. , a commercial stage biotechnology company with a primary focus in oncology, today announced that clinical data on ZEVALIN will be presented at the 51st Annual Meeting of the American Society of Hematology , being held December 5-8, 2009 at the Ernest N.
|
|
| 5.
|
Provectus Announces Preliminary Phase 2 Data For PH-10 in its Psoriasis and Atopic Dermatitis Trials
-
Business Wire
-
Tue 7:00 am ET
KNOXVILLE, Tenn.----Provectus Pharmaceuticals, Inc. , a development-stage oncology and dermatology biopharmaceutical company, announced preliminary data for the company’s PH-10 Phase 2 clinical trial for Psoriasis as well as for its Phase 2 clinical trial for Atopic Dermatitis.
|
|
| 6.
|
WHO approves Glaxo's swine flu shot
-
AP
-
Tue 6:19 am ET
Drug giant GlaxoSmithKline says one of its swine flu vaccines has been certified by the World Health Organization, making it available for donors to buy for developing countries.
|
|
| 7.
|
Indianapolis likely losing ATP event after decades
-
AP
-
Mon 5:04 pm ET
Organizers of the Indianapolis Tennis Championships are planning to sell the sanctioning rights for the ATP event, meaning the city may be without a professional tournament for the first time in more than 80 years.
|
|
| 8.
|
Court hears Vioxx lawsuit arguments
-
AP
-
Mon 3:54 pm ET
Lawyers for Merck & Co. told the Supreme Court Monday that investors waited too late and didn't do all of the necessary investigations to sue the drug maker over whether it properly warned about the risks of its blockbuster painkiller Vioxx.
|
|
| 9.
|
Health Care Company Acquisition Price By Private Equity 22% Over Predicted Price By Small Cap Expert
-
Wall Street Transcript
-
Mon 1:41 pm ET
67 WALL STREET, New York - November 26, 2009 - The Wall Street Transcript has just published its TWST Investing Strategies Report offering a timely review of the sector to serious investors and industry executives. This 55 page feature contains expert industry commentary through in-depth interviews with highly experienced Portfolio Managers. The full issue is available via The Wall Street Transcript Online.
|
|
| 10.
|
Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference
-
PR Newswire
-
Tue Nov 24
Keryx Biopharmaceuticals, Inc. today announced that Ron Bentsur, the Company's Chief Executive Officer, is scheduled to present at the Piper Jaffray 21st Annual Health Care Conference being held in New York City.
|
|
